Synapse - Prioty Islam

Prioty Islam

Research Focus

Medicine; Assistant Attending L1

https://orcid.org/0000-0002-2014-9318

Recent additions – View all

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL
Research Letter

Kittai, A. S.; Huang, Y.; Miller, S.; Allan, J. N.; Bhat, S. A.; Bond, D. A.; Brander, D. M.; Byrd, J. C.; Chavez, J. C.; Chong, E.; more...
Blood Cancer Journal (2025)

Fulltext@MSK | Save
A phase 2 study of minimal residual disease (MRD)-adapted front line venetoclax and obinutuzumab in fit patients with chronic lymphocytic leukemia (CLL): Effect of obinutuzumab on tumor lysis syndrome (TLS) risk and safety of outpatient venetoclax dose escalation
Meeting Abstract

Roeker, L. E.; Zelenetz, A. D.; Park, J. H.; Derkach, A.; Geyer, M. B.; Islam, P.; Falchi, L.; Palomba, M. L.; Kumar, A.; Salles, G.; more...
Blood (2023)

Fulltext@MSK | Save
Outcomes of patients with richter transformation without prior chemoimmunotherapy for CLL/SLL: An international multicenter retrospective study
Meeting Abstract

Kittai, A. S.; Huang, Y.; Miller, S.; Allan, J. N.; Bhat, S. A.; Bond, D. A.; Brander, D. M.; Byrd, J. C.; Chavez, J. C.; Chong, E. A.; more...
Blood (2023)

Fulltext@MSK | Save

Co-authors at MSK

3

Thompson
2

Roeker
1

Blesie
1

Coombs
1

Court
1

Derkach
1

Falchi
1

Falco
1

Geyer
1

Goldberg
1

Kumar
1

Lebowitz
1

Lue
1

Mato
1

Nogan
1

Palomba
1

Panton
1

Park
1

Salles
1

Shah
1

Soni
1

Tyznar
1

Zelenetz

Types of Work

Publications

Blood (2)
Blood Cancer Journal (1)
Current Treatment Options in Oncology (1)